12 results
History of Systemic Thrombolysis for Ischemic Stroke and Benefit in Neurologic Outcomes - Salim R. Rezaie
for Ischemic Stroke ... EBM #Neurology #Stroke ... #Thrombolytics ... #Evidence #Summary ... #Controversy #CVA
Contraindications to Thrombolytics

#Thrombolysis #Diagnosis #Management #Contraindications #Thrombolytics #TPA #STEMI #Stroke #CVA #Absolute #Relative
Contraindications to Thrombolytics ... #Thrombolysis ... Contraindications #Thrombolytics ... #TPA #STEMI #Stroke ... #CVA #Absolute
Alteplase (t-PA) for Acute Ischemic Stroke: 
Dosage, Mixing, and Administration Instructions

#TPA #Thrombolytics #Stroke #CVA #Dosage #Dosing
Acute Ischemic Stroke ... Instructions #TPA #Thrombolytics ... #Stroke #CVA #Dosage ... #Instructions #Pharmacology
Acute Stroke - Diagnosis and Management Summary

- Dr. Declan O'Kane @drokane

#CVA #stroke #summary #diagnosis #management #treatment
Acute Stroke - Diagnosis ... and Management Summary ... O'Kane @drokane #CVA ... #stroke #summary
tPA Code Stroke Dosing Chart

Total Dose = 0.9 mg/kg (maximum dose =90 mg)
 - give 10%
tPA Code Stroke ... #Dosing #Dose #CVA ... #Thrombolytics ... #Stroke #Pharmacology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... Summary Mechanisms ... canagliflozin ↓ CV ... - Strong Medicine ... #Summary #DM2 #
Summary of All RCTs to Date on Endovascular Therapy for Acute Ischemic Stroke 

#EBM #Neurology #NeuroInterventionalRadiology
Summary of All RCTs ... Acute Ischemic Stroke ... EndovascularTherapy #Stroke ... #CVA #RCT #Summary
Atorvastatin. HMG-CoA reductase inhibitor (statin) for dyslipidemia and MI/stroke prevention. 2nd most prescribed drug in the
HMG-CoA reductase ... dyslipidemia and MI/stroke ... #Pharmacology #Atorvastatin
Aortic Dissection - Diagnosis and Management Summary
 • HPI: sudden onset, "tearing" chest pain, radiation to
and Management Summary ... have concurrent stroke-like ... FHx • Imaging: CTA ... Diagnosis #Management #summary
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Summary Mechanisms ... variety of adverse CV ... - Strong Medicine ... #Summary #DM2 #